Raymond March | Friday June 22, 2018 at 9:00 AM PST | Comments Off on EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Increased competition is the remedy to skyrocketing drug prices.
Tags: AARP, competition, Daraprim, EpiPen, FDA, Food and Drug Administration, Heather Bresch, market pricing, Martin Shkreli, Mylan, pharmaceuticals, Turing Pharmaceuticals
Abigail R. Hall | Thursday May 19, 2016 at 1:00 PM PST | Comments Off on A Defense of “Big Bad Pharma”
Late last year Turing Pharmaceuticals provoked a serious backlash after hiking the price of the pill Daraprim from $13.50 to $750 per pill. The head of the company defended his firm against the criticism, but many found his arguments lacking. While we may question the overnight price jump of more than 5,400 percent, economics...
Read More »
Tags: Daraprim, drug prices, medication, pharmaceutical industry, pharmaceutical prices, prescription drug prices
